HERAMED LIMITED - Announcements

Market Cap $13.29M Add to my watchlist

Hera Med Ltd is an Israel-based company that develops pregnancy monitoring solutions for... Hera Med Ltd is an Israel-based company that develops pregnancy monitoring solutions for home and professional use. It offers hardware solutions supported by software applications. Its product HeraBEAT, is a medical-grade, clinically-validated and connected Ultrasound Fetal Doppler device predominantly for use by an expectant mother to self-monitor her fetus’ heart rate (FHR) at home. HeraBEAT communicates with any smartphone (iOS/Android) through Bluetooth Low Energy (BLE). A mother can hold or strap the HeraBEAT device to her abdomen, and the collected data is transmitted to her smartphone where the relevant readings are displayed through an interface. The Company also develops a service model which includes a homecare pregnancy solution. In addition, the Company develops artificial intelligence (AI), machine-learning, computerized algorithms to monitor and analyze the data so a healthcare professional or home user is informed of the wellbeing of the fetus.More

Announcements

Filter Results

All Price Sensitive Only

HMD	Orion Artificial Intelligence Presentation		26/03/19	Share
HMD	Dr Arturo Weschler MD Appointed to Lead Orion AI Operations		26/03/19	Share
HMD	Quasar Manufacturing Agreement to Deliver Scale & Efficiency	PRICE SENSITIVE	13/03/19	Share
HMD	Appendix 4E & Preliminary Final Report	PRICE SENSITIVE	28/02/19	Share
HMD	Major Brazilian Health Care Group Places Initial Pilot Order	PRICE SENSITIVE	14/02/19	Share
HMD	December Quarterly Activity Report & Appendix 4C	PRICE SENSITIVE	31/01/19	Share
HMD	Australian Distribution Agreement for 9000 HeraBEAT Units	PRICE SENSITIVE	14/01/19	Share
HMD	December Investor Presentation		19/12/18	Share
HMD	Becoming a substantial holder - Holley Pharmaceutical Group		19/12/18	Share
HMD	HeraMED Completes Over-Subscribed $6 Million IPO		12/12/18	Share
HMD	Becoming a substantial holder - Tal Slonim		11/12/18	Share
HMD	Becoming a substantial holder - David Groberman		11/12/18	Share
HMD	Initial Director's Interest Notice - Tal Slonim		11/12/18	Share
HMD	Initial Director's Interest Notice - Ronald Weinberger		11/12/18	Share
HMD	Initial Director's Interest Notice - Doron Birger		11/12/18	Share
HMD	Initial Director's Interest Notice - David Hinton		11/12/18	Share
HMD	Initial Director's Interest Notice - David Groberman		11/12/18	Share
HMD	Statement of Confirmations		10/12/18	Share
HMD	Updated Statement of Commitments		10/12/18	Share
HMD	Voluntary Escrow		10/12/18	Share
HMD	Restricted Securities		10/12/18	Share
HMD	Updated Pro Forma Statement of Financial Position		10/12/18	Share
HMD	Capital Structure		10/12/18	Share
HMD	Securities Trading Policy		10/12/18	Share
HMD	Hera Med Ltd. Half Yearly Accounts to 30 June 2018		10/12/18	Share
HMD	Hera Med Ltd. 2016 and 2017 Full Year Accounts		10/12/18	Share
HMD	Supplementary Prospectus		10/12/18	Share
HMD	Prospectus		10/12/18	Share
HMD	Constitution		10/12/18	Share
HMD	Appendix 1A and Information Form and Checklist		10/12/18	Share
HMD	Top 20 Holders		10/12/18	Share
HMD	Distribution Schedule		10/12/18	Share
HMD	ASX Notice - Admission to Official List		10/12/18	Share

HMD Orion Artificial Intelligence Presentation
26/03/19		Share
HMD Dr Arturo Weschler MD Appointed to Lead Orion AI Operations
26/03/19		Share
HMD Quasar Manufacturing Agreement to Deliver Scale & Efficiency
13/03/19	PRICE SENSITIVE	Share
HMD Appendix 4E & Preliminary Final Report
28/02/19	PRICE SENSITIVE	Share
HMD Major Brazilian Health Care Group Places Initial Pilot Order
14/02/19	PRICE SENSITIVE	Share
HMD December Quarterly Activity Report & Appendix 4C
31/01/19	PRICE SENSITIVE	Share
HMD Australian Distribution Agreement for 9000 HeraBEAT Units
14/01/19	PRICE SENSITIVE	Share
HMD December Investor Presentation
19/12/18		Share
HMD Becoming a substantial holder - Holley Pharmaceutical Group
19/12/18		Share
HMD HeraMED Completes Over-Subscribed $6 Million IPO
12/12/18		Share
HMD Becoming a substantial holder - Tal Slonim
11/12/18		Share
HMD Becoming a substantial holder - David Groberman
11/12/18		Share
HMD Initial Director's Interest Notice - Tal Slonim
11/12/18		Share
HMD Initial Director's Interest Notice - Ronald Weinberger
11/12/18		Share
HMD Initial Director's Interest Notice - Doron Birger
11/12/18		Share
HMD Initial Director's Interest Notice - David Hinton
11/12/18		Share
HMD Initial Director's Interest Notice - David Groberman
11/12/18		Share
HMD Statement of Confirmations
10/12/18		Share
HMD Updated Statement of Commitments
10/12/18		Share
HMD Voluntary Escrow
10/12/18		Share
HMD Restricted Securities
10/12/18		Share
HMD Updated Pro Forma Statement of Financial Position
10/12/18		Share
HMD Capital Structure
10/12/18		Share
HMD Securities Trading Policy
10/12/18		Share
HMD Hera Med Ltd. Half Yearly Accounts to 30 June 2018
10/12/18		Share
HMD Hera Med Ltd. 2016 and 2017 Full Year Accounts
10/12/18		Share
HMD Supplementary Prospectus
10/12/18		Share
HMD Prospectus
10/12/18		Share
HMD Constitution
10/12/18		Share
HMD Appendix 1A and Information Form and Checklist
10/12/18		Share
HMD Top 20 Holders
10/12/18		Share
HMD Distribution Schedule
10/12/18		Share
HMD ASX Notice - Admission to Official List
10/12/18		Share

REFRESH

(20min delay)
Last 2.2¢		Change 0.000(0.00%)		Mkt cap ! $13.29M

Open	High	Low	Value	Volume
0.0¢	0.0¢	0.0¢	$0	0

Buyers (Bids)

No.	Vol.	Price($)
4	2159312	2.1¢

Sellers (Offers)

Price($)	Vol.	No.
2.3¢	412070	1

View Market Depth

No.	Vol.	Price($)
3	1079500	0.020
1	998971	0.018
1	1000000	0.017
3	1242548	0.015
1	200000	0.014

Price($)	Vol.	No.
0.024	200000	1
0.025	72222	1
0.026	156429	1
0.027	150000	1
0.028	150000	1

Last trade - 10.04am 25/11/2024 (20 minute delay)

HMD (ASX) Chart

Day chart unavailable